DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features

Pigment Cell and Melanoma Research

Volumn 27, Issue 6, 2014, Pages 1097-1105

  Thomas, Nancy E ^a,b   Slater, Nathaniel A ^a   Edmiston, Sharon N ^b   Zhou, Xin ^c   Kuan, Pei Fen ^b,c   Groben, Pamela A ^a   Carson, Craig C ^a   Hao, Honglin ^a   Parrish, Eloise ^b   Moschos, Stergios J ^a,b   Berwick, Marianne ^d   Ollila, David W ^a,b   Conway, Kathleen ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

CpG island methylator phenotype; Global methylation patterns; Melanoma; Methylation; Methylation clusters or subgroups; Pathologic features; Primary melanoma

Indexed keywords

B RAF KINASE;

ADULT; AGED; ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; CPG ISLAND; DNA METHYLATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MELANOMA; MITOSIS RATE; CLUSTER ANALYSIS; DEMOGRAPHY; GENE LOCUS; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PHENOTYPE; PROMOTER REGION; REPRODUCIBILITY; SKIN TUMOR;

ADULT; AGED; CLUSTER ANALYSIS; CPG ISLANDS; DEMOGRAPHY; DNA METHYLATION; FEMALE; GENETIC LOCI; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS;

EID: 84911411640     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12289     Document Type: Article

References (25)

1. Balch, C.M., Gershenwald, J.E., Soong, S.J. et al. (2009). Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 6199-6206.
2. Broad Institute TCGA Data Analysis Center (2014a). Clustering of Methylation: consensus NMF. Broad Institue of MIT and Harvard. doi: 10.7908/C1Q81BRQ.
3. Broad Institute TCGA Data Analysis Center (2014b). Correlation between mRNA expression and DNA methylation. Broad Institue of MIT and Harvard. doi:10.7908/C1765D05.
4. Conway, K., Edmiston, S.N., Khondker, Z.S. et al. (2011). DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res. 24, 352-360.
5. Dunn, J.C. (1973). A fuzzy relative of the ISODATA Process and Its Use in Detecting Compact Well-Separated Clusters. Cybernetics and Systems 3, 32-57.
6. Gao, L., Smit, M.A., van den Oord, J.J. et al. (2013). Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma. Pigment Cell Melanoma Res. 26, 542-554.
7. Greenberg, E.S., Chong, K.K., Huynh, K.T., Tanaka, R., and Hoon, D.S. (2012). Epigenetic biomarkers in skin cancer. Cancer Lett. 342, 170-177.
8. Hoshimoto, S., Kuo, C.T., Chong, K.K., Takeshima, T.L., Takei, Y., Li, M.W., Huang, S.K., Sim, M.S., Morton, D.L., and Hoon, D.S. (2012). AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J. Invest. Dermatol. 132, 1689-1697.
9. Hou, P., Liu, D., Dong, J., and Xing, M. (2012). The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells. Cell Cycle 11, 286-295.
10. Hughes, L.A., Melotte, V., de Schrijver, J. et al. (2013). The CpG Island Methylator Phenotype: What's in a Name? Cancer Res. 73, 5858-5868.
11. Jonsson, A., Tuominen, R., Grafström, E., Hansson, J., and Egyhazi, S. (2010). High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma. J. Invest. Dermatol. 130, 2809-2817.
12. Koga, Y., Pelizzola, M., Cheng, E., Krauthammer, M., Sznol, M., Ariyan, S., Narayan, D., Molinaro, A.M., Halaban, R., and Weissman, S.M. (2009). Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res. 19, 1462-1470.
13. Larson, A.R., Dresser, K.A., Zhan, Q. et al. (2014). Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Mod. Pathol. 27, 936-944.
14. Lian, C.G., Xu, Y., Ceol, C. et al. (2012). Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150, 1135-1146.
15. Liu, D., Liu, X., and Xing, M. (2012). Epigenetic genes regulated by the BRAFV600E signaling are associated with alterations in the methylation and expression of tumor suppressor genes and patient survival in melanoma. Biochem. Biophys. Res. Commun. 425, 45-50.
16. Marsit, C.J., Christensen, B.C., Houseman, E.A. et al. (2009). Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 30, 416-422.
17. Marzese, D.M., Scolyer, R.A., Huynh, J.L. et al. (2013). Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum. Mol. Genet. 23, 226-238.
18. Rakosy, Z., Ecsedi, S., Toth, R. et al. (2013). Integrative genomics identifies gene signature associated with melanoma ulceration. PLoS ONE 8, e54958.
19. Rebhan, M., Chalifa-Caspi, V., Prilusky, J., and Lancet, D. (1998). GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics 14, 656-664.
20. Sigalotti, L., Covre, A., Fratta, E., Parisi, G., Sonego, P., Colizzi, F., Coral, S., Massarut, S., Kirkwood, J.M., and Maio, M. (2012). Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. J. Transl. Med. 10, 185.
21. Tanemura, A., Terando, A.M., Sim, M.S., van Hoesel, A.Q., de Maat, M.F., Morton, D.L., and Hoon, D.S. (2009). CpG island methylator phenotype predicts progression of malignant melanoma. Clin. Cancer Res. 15, 1801-1807.
22. Tellez, C.S., Shen, L., Estecio, M.R., Jelinek, J., Gershenwald, J.E., and Issa, J.P. (2009). CpG island methylation profiling in human melanoma cell lines. Melanoma Res. 19, 146-155.
23. Thomas, N.E., Alexander, A., Edmiston, S.N., Parrish, E., Millikan, R.C., Berwick, M., Groben, P., Ollila, D.W., Mattingly, D., and Conway, K. (2004). Tandem BRAF mutations in primary invasive melanomas. J. Invest. Dermatol. 122, 1245-1250.
24. Thomas, N.E., Edmiston, S.N., Alexander, A. et al. (2007). Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol. Biomarkers Prev. 16, 991-997.
25. Van den Hurk, K., Niessen, H.E., Veeck, J., van den Oord, J.J., van Steensel, M.A., Zur Hausen, A., van Engeland, M., and Winnepenninckx, V.J. (2012). Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune. Biochim. Biophys. Acta 1826, 89-102.